Community Collective: Harnessing the Power of the Community to Battle Obesity is an educational curriculum designed for primary care clinicians to enhance outcomes for individuals with obesity through improved diagnosis and use of anti-obesity medications (AOMs). This regional series consists of three individual activities (2 live-virtual and 1 live in-person) tailored to the educational needs of US clinicians who treat patients with obesity and practice in geographic areas with a greater prevalence of the disease. National and local experts in the treatment of obesity will discuss the risk factors and comorbidities associated with obesity, strategies to conduct a thorough diagnosis of obesity, the latest safety and efficacy data for recently approved and emerging AOMs, as well as approaches to the optimal use of AOMs with shared decision-making. Community Collective is designed to facilitate networking and collaborative consultation among local clinicians and obesity experts in your area.
This activity is planned for primary care physicians, NPs, and PAs who treat individuals with obesity throughout the US.
Sandra Christensen, MSN, ARNP, FNP-BC
Integrative Medical Weight Management
Obesity Medicine Association Trustee
Washington Obesity Society Trustee
After completing this CE activity, the participant should be better able to:
- Identify risk factors and common medical consequences and comorbidities of the chronic disease of obesity
- Conduct a thorough diagnosis, including waist circumference, for patients who may have overweight/obesity
- Evaluate the safety and efficacy of the most recently approved and emerging AOMs
- Appropriately discuss effective weight loss options, including new and emerging pharmacotherapies, through a shared decision-making approach
Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA Credit Designation Statement
Interprofessional Continuing Education (IPCE) Statement
Disclosure & Conflict of Interest Policy
Medical Learning Institute, Inc., is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.
Tonia Vinton, MD
Department of Internal Medicine
UT Southwestern Medical Center
Tonia Vinton, MD, has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Anita Punjabi Bajpai, MD
Baylor Scott & White Health
Anita Punjabi Bajpai, MD, has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Lily Han, MD
Fellow of the American Academy of Pediatrics
Diplomate of the American Board of Obesity Medicine
Diplomate of the American Board of Lifestyle Medicine
Cook Children’s Physician Network
Lily Han, MD, has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Richa Mittal, MD
Founder & Medical Director
Radiant Health Weight Loss and Wellness
Richa Mittal, MD, has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Scott D. Isaacs, MD, FACP, FACE
Adjunct Associate Professor of Medicine
Emory University School of Medicine
Scott D. Isaacs, MD, FACP, FACE, has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Robert F. Kushner, MD
Professor, Departments of Medicine and Medical Education
Northwestern University Feinberg School of Medicine
Robert F. Kushner, MD, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant: Altimmune, Boehringer Ingelheim, Lilly, Novo Nordisk, Pfizer, Weight Watchers
Holly F. Lofton, MD, DABOM
Clinical Associate Professor of Surgery and Medicine
Director, Medical Weight Management Program
NYU Langone Weight Management Program
New York, NY
Holly F. Lofton, MD, DABOM, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant: Novo Nordisk
Research Grant: Eli Lilly, Novo Nordisk
Speakers’ Bureau: Novo Nordisk
The following relationships have ended within the last 24 months:
Advisory Board/Consultant: Currax
All of the relevant financial relationships of individuals for this activity have been mitigated.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider, do not have any relevant financial relationships to disclose with ineligible companies unless listed below.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the activity evaluation form and your certificate of credit will be generated. You will receive your certificate from Medical Learning Institute, Inc.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
If you have questions regarding your certificate, please contact MLI at firstname.lastname@example.org.
About This Activity
Medical Learning Institute, Inc. is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute, Inc.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters.
Copyright © 2023 Medical Learning Institute, Inc. All Rights Reserved.
- Activity 1: Virtual Live (via Zoom)
Thursday, April 4, 2024 | 6:00 PM – 7:00 PM PT
Importance of conversations about an obesity diagnosis
- Activity 2: Virtual Live (via Zoom)
Thursday, April 11, 2024 | 6:00 PM – 7:00 PM PT
Practical application of new and emerging data
- Activity 3: Live In-Person (venue TBD)
Thursday, April 18, 2024 | 6:30 PM – 8:30 PM PT
Q&A, case consults, building a network, spreading the word
This activity is supported by an educational grant from Lilly